Apollo Scientific @ InformEx USA 2010, stand 535

Published: 10-Feb-2010

Apollo Scientific is a worldwide supplier of a broad and impressively diverse range of intermediates from lab-scale to commercial quantities. At present we have a total of more than 44,000 products across all our ranges. These include almost 13,000 fluorine containing compounds, 27,000 non-fluorinated intermediates, 1,000 high purity inorganic salts and more than 2,500 reagents for plant and molecular biology.
Central Glass Inc (Japan) is now the majority shareholder in Apollo and this gives us the facility to support your project from conception to commercial realisation.
  • Companies:
  • Informa
See more

You may also like

Packaging

Pharmapack announces expansion to Asia with new event in Singapore, set for November 2026

Read more
Pharmapack, the leading European platform for pharmaceutical packaging and drug delivery innovation, announces the launch of Pharmapack Asia, coming to Singapore in November 2026

Trending Articles

  1. NHS, MHRA and Medicines UK launch Project Revive to tackle medicine shortages NHS England, the MHRA and Medicines UK have launched Project Revive, a collaborative pilot designed to address critical medicines shortages by fast-tracking dormant MHRA-approved licences and creating dedicated NHS purchasing arrangements to improve long-term supply resilience
  2. Isopod Rapid Cleanrooms: the ideal elite controlled environment pod solution for Life Sciences and Engineering start-ups The Guardtech Group’s quick-assembly cleanroom pods combine superior performance, build quality and cost-effectiveness to give new applications the perfect platform to get their business up and running
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Delivering precision: why advanced therapies are redefining pharmaceutical logistics As advanced therapies narrow tolerances and personalise care, pharmaceutical logistics is being redefined as a precision-driven extension of treatment delivery, writes Michael Gardner, Head of Pharma Specialised Network at DHL Supply Chain
  4. Nose-to-brain delivery outperforms systemic BBB technologies according to MetP Pharma The pioneering company has published preclinical data that strongly supports the advantages of its proprietary nose-to-brain drug delivery technology compared with systemic blood-brain barrier transporter approaches. The results also suggest strong support for therapeutically relevant clinical effects of semaglutide using MetP Pharma’s DDT
  5. AstraZeneca strengthens weight management pipeline with CSPC Pharmaceuticals collaboration The pair have signed a strategic collaboration covering eight obesity and type 2 diabetes programmes, including a clinical-ready GLP-1/GIP asset, AI-driven peptide discovery capabilities and injectable dosing technology

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual See all

You may also like

Packaging

Pharmapack announces expansion to Asia with new event in Singapore, set for November 2026

Pharmapack, the leading European platform for pharmaceutical packaging and drug delivery innovation, announces the launch of Pharmapack Asia, coming to Singapore in November 2026
Marketing

CPHI Pharma Awards 2025 winners announced

Hundreds of entries received across 13 categories showcasing industry-wide excellence
Pharmaceutical

Pharma leaders to join together to shape the future of the industry at CPHI Frankfurt Leadership Summit

As the pharmaceutical industry enters a defining period of transformation, Informa Markets is hosting an exclusive Leadership Summit at this year’s CPHI Frankfurt, bringing together some of the sector’s most influential executives to address the challenges and opportunities shaping global healthcare
Manufacturing

CPHI & PMEC China sees surge in international attendance as globalpharma trade outlook strengthens

Record international participation reflects renewed momentum in pharma manufacturing and global sourcing,as easing tariffs fuel growth
You need to be a subscriber to read this article.
Click here to find out more.
Packaging

Of data, devices and drug delivery

Ahead of Pharmapack Europe 2025 (22–23January, Paris, France), Dr Kevin Robinson (KSR) spoke with three pharma leaders about the big trends that will drive and influence the pharmaceutical sector in 2025
Manufacturing

Faster CDMO growth in 2025 predicted and industry not in favour of BIOSECURE Act, states CPHI Milan survey

CPHI Milan returns next month at a pivotal moment as contract services growth is predicted to accelerate in 2025
Pharmaceutical

CPHI Milan announces the finalists for 14 categories of the Pharma Awards

Awards for future leaders, women of the year and those at the heart of pharma will be handed out at the CPHI Pharma Awards ceremony
Subscribe now